- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Indolent Lymphoma
Total 9660 results
-
Mustang BioNational Cancer Institute (NCI)RecruitingMantle Cell Lymphoma Recurrent | Mantle Cell Lymphoma Refractory | Small Lymphocytic Lymphoma, Relapsed | Waldenstrom's Macroglobulinemia Recurrent | Follicular B-cell Non-Hodgkin's Lymphoma | B-cell Lymphoma Refractory | Waldenstrom's Macroglobulinemia Refractory | Chronic Lymphoid Leukemia in RelapseUnited States
-
Shanghai Henlius BiotechCompleted
-
University Hospital, ToulouseRecruitingMastocytosis, Indolent SystemicFrance
-
Atara BiotherapeuticsRecruitingHigh-grade B-cell Lymphoma | MCL | Diffuse Large B-cell Lymphoma (DLBCL) | Relapsed/Refractory B-cell Non-Hodgkin Lymphoma | DLBCL/High-grade B-cell Lymphoma With MYC and BCL2 Rearrangements | Anaplastic Lymphoma Kinase-Positive Large B-Cell Lymphoma | LBCL With IRF4 Rearrangement | High-grade B-cell... and other conditionsUnited States
-
Peking UniversityUniversity of FloridaUnknown
-
Dong-A University HospitalSamsung Medical Center; Asan Medical Center; Chonnam National University Hospital and other collaboratorsCompletedB-cell LymphomasKorea, Republic of
-
Samsung Medical CenterJanssen Medical AffairsCompletedNon-Hodgkin Lymphoma | Peripheral T-Cell LymphomasKorea, Republic of
-
ADC Therapeutics S.A.Withdrawn
-
Grupo Español de Linfomas y Transplante Autólogo...Completed
-
Ahmed Galal, MDWithdrawnB Cell LymphomasUnited States
-
Oncology Specialists, S.C.University of Illinois at ChicagoTerminatedNon-Hodgkin LymphomasUnited States
-
Fudan UniversityUnknownChemotherapy | T-Cell LymphomasChina
-
National Health Research Institutes, TaiwanNational Taiwan University Hospital; China Medical University Hospital; Chang... and other collaboratorsNot yet recruitingPeripheral T-cell Lymphomas (PTCL)Taiwan
-
Assistance Publique - Hôpitaux de ParisActive, not recruitingEpidermotropic T-cell LymphomasFrance
-
Memorial Sloan Kettering Cancer CenterUniversity of NebraskaCompletedT-cell Lymphomas | Relapsed or RefractoryUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); The Wayne D. Kuni and Joan E. Kuni FoundationCompletedDiffuse Large B-Cell Lymphoma | Acute Myeloid Leukemia | Refractory Hodgkin Lymphoma | Previously Treated Myelodysplastic Syndrome | Recurrent Mantle Cell Lymphoma | Waldenstrom Macroglobulinemia | Acute Lymphoblastic Leukemia | Refractory Plasma Cell Myeloma | Recurrent Small Lymphocytic Lymphoma | Refractory... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterDana-Farber Cancer Institute; Stanford UniversityActive, not recruitingLymphoma | Relapsed/Refractory T-cell LymphomasUnited States
-
St. Jude Children's Research HospitalCompletedLymphoblastic LymphomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Marginal Zone Lymphoma | Waldenstrom Macroglobulinemia | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma and other conditionsUnited States
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.TerminatedRelapsed Cutaneous T Cell LymphomChina
-
VelosBio Inc., a subsidiary of Merck & Co., Inc...CompletedFollicular Lymphoma | Acute Myeloid Leukemia | Burkitt Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B-cell Lymphoma | Acute Lymphoid Leukemia | Richter Transformation Lymphoma | Lymphoplasmacytoid Lymphoma | T-cell Non-Hodgkin...United States
-
AstraZenecaCLL ConsortiumCompletedB Cell Lymphomas | 11q-deleted Relapsed/Refractory Chronic Lymphocytic Leukaemia (CLL), | Prolymphocytic Leukaemia (PLL)United States
-
M.D. Anderson Cancer CenterRecruitingRefractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Richter Syndrome | Refractory Mantle Cell Lymphoma | Refractory Aggressive B-Cell Non-Hodgkin Lymphoma | Refractory High Grade B-Cell Lymphoma | Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma | Refractory... and other conditionsUnited States
-
Lapo AlinariRecruitingRecurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Refractory High Grade B-Cell Lymphoma With MYC... and other conditionsUnited States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruitingChronic Lymphoid Leukemia | Large-B-cell Diffuse LymphomaItaly
-
Nanjing NingQi Medicine Science and Technology...Jiangsu Cancer Institute & HospitalUnknownPeripheral T-cell LymphomasChina
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory T-cell LymphomasJapan
-
University of PennsylvaniaCompletedNon-Hodgkins Lymphoma (NHL) Patients, With CD19+B Cell LymphomasUnited States
-
Abramson Cancer Center at Penn MedicineCompletedFollicular Lymphoma | Waldenstrom Macroglobulinemia | Mantle-Cell Lymphoma | Lymphoma, Small Lymphocytic | Marginal Zone B-Cell Lymphoma | MALT Lymphoma | Lymphoma of Mucosa-Associated Lymphoid TissueUnited States
-
International Extranodal Lymphoma Study Group (IELSG)Active, not recruitingMucosa Associated Lymphoid Tissue (MALT) LymphomaSpain, Italy, Austria
-
Chinese PLA General HospitalUnknownMantle Cell Lymphoma | Hematopoietic/Lymphoid Cancer | Non-hodgkin Lymphoma,B CellChina
-
Ohio State University Comprehensive Cancer CenterCompletedIndolent or Intermediate Grade B-cell MalignancyUnited States
-
AbbVieGenentech, Inc.Active, not recruitingNon-Hodgkin's Lymphoma | Hematological Malignancies | Chronic Lymphoid Leukemia | CD20-Positive Lymphoid MalignanciesUnited States, Australia
-
Eureka Therapeutics Inc.Duke University; Duke Clinical Research InstituteTerminatedLymphomas Non-Hodgkin's B-CellUnited States
-
University Hospital, BrestTeva Pharmaceuticals USATerminatedCerebral Lymphoma B Cell RefractoryFrance
-
Ajou University School of MedicineUnknownLymphoblastic LymphomaKorea, Republic of
-
Fondazione Italiana Linfomi ONLUSUnknown
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Anhui Provincial HospitalUnknownFollicular Lymphoma | B Cell Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | Plasma Cell Neoplasm | Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Primary Cutaneous Follicle Centre LymphomaChina
-
National Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Splenic Marginal Zone Lymphoma | Recurrent Small Lymphocytic LymphomaUnited States
-
Medical College of WisconsinRecruitingFollicular Lymphoma | Multiple Myeloma | Burkitt Lymphoma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Lymphoma, Small Lymphocytic | Diffuse Large B Cell Lymphoma | Central Nervous System Lymphoma | Lymphomas Non-Hodgkin's B-CellUnited States
-
University of WashingtonBayerTerminatedNon-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Lymphoid LeukemiaUnited States
-
National Cancer Institute (NCI)RecruitingImmune System Diseases | Lymphoproliferative Disorders | Peripheral T-cell LymphomasUnited States
-
The Lymphoma Academic Research OrganisationCompletedFollicular Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Mucosa Associated Lymphoid TissueFrance
-
Ontario Clinical Oncology Group (OCOG)Sunnybrook Health Sciences Centre; Genzyme, a Sanofi CompanyCompletedAlemtuzumab and CHOP Chemotherapy for Aggressive Histological Peripheral T-Cell Lymphomas (ACCAPELA)Peripheral T-cell LymphomasCanada
-
International Extranodal Lymphoma Study Group (IELSG)CompletedLymphoma, Mucosa-Associated Lymphoid TissueSwitzerland
-
Gilead SciencesTerminatedFollicular Lymphoma | Small Lymphocytic LymphomaUnited States
-
Cancer Institute and Hospital, Chinese Academy...CompletedLymphoid NeoplasmChina
-
Antengene Biologics LimitedRecruitingAdvanced Solid Tumors | B-cell Non-Hodgkin LymphomasUnited States
-
Robert LowskyNational Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone Lymphoma | Recurrent Small Lymphocytic...United States
-
David Bond, MDBristol-Myers SquibbActive, not recruitingDiffuse Large B-Cell Lymphoma | Aggressive Non-Hodgkin Lymphoma | Indolent Non-Hodgkin Lymphoma | Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma | High Grade B-Cell Lymphoma, Not Otherwise Specified | Transformed Non-Hodgkin Lymphoma | Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma | Ann Arbor Stage... and other conditionsUnited States